• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cancer drugs

FDA
Favicon Fierce Pharma

New FDA oncology chief sets priorities in first interview

Hiring more staff and deploying AI are among the OCE’s priorities, Angelo de Claro told Fierce in his first interview as FDA’s oncology chief.
Angus Liu Sep 11, 2026 4:00am
Graphic image of a red thumbs down against a blue background
Favicon Fierce Pharma

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
Field of flowers with a rainbow behind

BlossomHill eyes IPO to grow taller in crowded cancer fields

Jul 17, 2026 12:08pm
pipeline pipes RD research

BeOne shelves 5 cancer programs, halts ph. 2 arthritis trial

May 7, 2026 11:15am
Najat Khan

Recursion's new CEO is bringing the AI outfit back to earth

May 6, 2026 6:30am
Kestrel perched on a branch

AbbVie dips into boiling RAS waters with $1.45B biobucks deal

Apr 28, 2026 10:01am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings